Brain Neoplasms - Mortality
Research News and Information

Thursday, March 18, 2010

Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma.

11 Oct 2009 BACKGROUND: Clinical trials involving patients with glioblastoma (GBM) distinguish cohorts who are treated with enzyme-inducing anticonvulsants (EIAC). Such anticonvulsants induce hepatic P450 microsomal enzymes, which accelerate the metabolism of ... Read more...

Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma.

11 Oct 2009 BACKGROUND: Bevacizumab has recently been approved by the US Food and Drug Administration for recurrent glioblastoma (GBM). However, patterns of relapse, prognosis, and outcome of further therapy after bevacizumab failure have not been studied ... Read more...

Microscopic thrombi in glioblastoma multiforme do not predict the development of deep venous thrombosis.

29 Sep 2009 Patients with glioblastoma multiforme (GBM) are known to be at risk for hypercoagulable events. Tumoral intravascular thrombi likely contribute to the development of hypoxia and necrosis. The purpose of this study was to assess whether there is a ... Read more...

Latest indexed articles for 'Brain Neoplasms - Mortality'

These are the very latest articles for this heading:

• American College of Radiology appropriateness criteria on multiple brain metastases. 13 Nov 2009
• Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma. 11 Oct 2009
• Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma. 11 Oct 2009
• Microscopic thrombi in glioblastoma multiforme do not predict the development of deep venous thrombosis. 29 Sep 2009
• Comment on "Hypericin uptake: a prognostic marker for survival in high-grade glioma". 29 Sep 2009
• Analysis of IDH1 and IDH2 mutations in Japanese glioma patients. 29 Sep 2009
• Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004). 7 Sep 2009
• Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. 30 Aug 2009
• Population-based study of pseudoprogression after chemoradiotherapy in GBM. 30 Aug 2009
• Neurological mortality among U.S. veterans of the Persian Gulf War: 13-year follow-up. 30 Aug 2009
• Gamma Knife surgery for brain metastases from gastrointestinal cancer. 30 Aug 2009
• Gamma Knife radiosurgery to the surgical cavity following resection of brain metastases. 30 Aug 2009
• Thirty years' experience with Gamma Knife surgery for metastases to the brain. 30 Aug 2009
• Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic. 30 Aug 2009
• Limited role of surgery in the management of primary central nervous system lymphoma (Review). 30 Aug 2009
• Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts. 30 Aug 2009
• In this issue... 30 Aug 2009
• [Proton beam therapy in pediatric radiotherapy] 16 Aug 2009
• Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007). 13 Aug 2009
• Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas. 2 Aug 2009

See a longer list of these articles.

Technical information about 'Brain Neoplasms'

Definition: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Descriptor UI: D001932

Alternative terms: Brain Neoplasms; Neoplasms, Brain; Brain Neoplasm; Neoplasm, Brain; Brain Tumors; Brain Tumor; Tumor, Brain; Tumors, Brain; Brain Cancer; Brain Cancers; Cancer, Brain; Cancers, Brain; Malignant Neoplasms, Brain; Brain Malignant Neoplasm; Brain Malignant Neoplasms; Malignant Neoplasm, Brain; Cancer of Brain; Cancer of the Brain; Neoplasms, Brain, Malignant; Brain Neoplasms, Malignant; Brain Neoplasm, Malignant; Malignant Brain Neoplasm; Malignant Brain Neoplasms; Neoplasms, Intracranial; Intracranial Neoplasm; Neoplasm, Intracranial; Intracranial Neoplasms; Brain Tumor, Recurrent; Brain Tumors, Recurrent; Recurrent Brain Tumor; Recurrent Brain Tumors; Malignant Primary Brain Tumors; Primary Malignant Brain Tumors; Malignant Primary Brain Neoplasms; Primary Malignant Brain Neoplasms; Brain Neoplasms, Malignant, Primary; Brain Neoplasms, Primary Malignant; Benign Neoplasms, Brain; Benign Neoplasm, Brain; Brain Benign Neoplasm; Brain Benign Neoplasms; Neoplasms, Brain, Benign; Brain Neoplasms, Benign; Benign Brain Neoplasm; Benign Brain Neoplasms; Brain Neoplasm, Benign; Brain Tumor, Primary; Brain Tumors, Primary; Primary Brain Tumor; Primary Brain Tumors; Neoplasms, Brain, Primary; Primary Brain Neoplasms; Brain Neoplasm, Primary; Brain Neoplasms, Primary; Primary Brain Neoplasm;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.588.614.250.195; C10.228.140.211; C10.551.240.250;

Technical Notes: /blood supply /chem /second /secret /ultrastruct permitted; coord IM with specific site in brain (IM) + histol type of neopl (IM)